0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Drug Therapy
 161-180 of 588 Articles
Viewpoint | 
Aaron S. Kesselheim, MD, JD, MPH; Michael D. Green, JD; Jerry Avorn, MD
JAMA. 2013;310(10):1023-1024. doi:10.1001/jama.2013.228349.

JAMA Clinical Challenge | 
Hsien-Yi Chiu, MD; Hsien-Ching Chiu, MD
JAMA. 2013;310(10):1068-1069. doi:10.1001/jama.2013.276214.

Comment & Response | 
Jashin J. Wu, MD
JAMA. 2013;310(10):1075-1076. doi:10.1001/jama.2013.276749.

Comment & Response | 
April W. Armstrong, MD, MPH
JAMA. 2013;310(10):1076. doi:10.1001/jama.2013.276767.

Medical News & Perspectives | 
Bridget M. Kuehn, MSJ
JAMA. 2013;310(10):1014. doi:10.1001/jama.2013.277673.

Editorial | 
J. Michael Gaziano, MD, MPH
JAMA. 2013;310(9):910-911. doi:10.1001/jama.2013.277066.

Original Investigation |  FREE
Simon Thom, MB,BS, MD; Neil Poulter, MB, MSc, FMedSci; Jane Field, BSc; et al.
JAMA. 2013;310(9):918-929. doi:10.1001/jama.2013.277064.
Includes: CME, Supplemental Content

Viewpoint | 
Stephen MacMahon, DSc, FMedSci; Vlado Perkovic, MBBS, PhD; Anushka Patel, MBBS, PhD
JAMA. 2013;310(9):907-908. doi:10.1001/jama.2013.276913.

Comment & Response | 
Ayman Sofiyan, MBBS; Ralph K. H. Nanan, Dr Med Habil, FRACP
JAMA. 2013;310(8):853. doi:10.1001/jama.2013.124263.

Comment & Response | 
Sina Gallo, RD, PhD; Celia Rodd, MD, MSc; Hope Weiler, RD, PhD
JAMA. 2013;310(8):853-854. doi:10.1001/jama.2013.124272.

Medical News & Perspectives | 
Bridget M. Kuehn, MSJ
JAMA. 2013;310(8):785. doi:10.1001/jama.2013.276938.

From JAMA's Daily News Site | 
JAMA. 2013;310(8):785. doi:10.1001/jama.2013.254573.

JAMA Patient Page |  FREE
Deborah Tolmach Sugerman, MSW
JAMA. 2013;310(8):866. doi:10.1001/jama.2013.58662.
Includes: Supplemental Content

News From the Centers for Disease Control and Prevention | 
JAMA. 2013;310(8):789. doi:10.1001/jama.2013.194488.

Capitol Health Call | 
Mike Mitka, MSJ
JAMA. 2013;310(6):572. doi:10.1001/jama.2013.192555.

Comment & Response | 
Heleen Moed, PhD; Esther Röder, MD, PhD; Patrick Bindels, MD, PhD
JAMA. 2013;310(6):644. doi:10.1001/jama.2013.7643.

Comment & Response | 
Franco Frati, MD; Cristoforo Incorvaia, MD; Giovanni Passalacqua, MD
JAMA. 2013;310(6):643-644. doi:10.1001/jama.2013.7646.

Comment & Response | 
Ishak Mansi, MD; Eric M. Mortensen, MD, MSc
JAMA. 2013;310(6):645-646. doi:10.1001/jama.2013.8519.

Comment & Response | 
Sandra Y. Lin, MD; Catalina Suarez-Cuervo, MD; Jodi Segal, MD, MPH
JAMA. 2013;310(6):644-645. doi:10.1001/jama.2013.7652.

Comment & Response | 
Martin J. London, MD; Gregory G. Schwartz, MD, PhD; William G. Henderson, PhD, MPH
JAMA. 2013;310(6):646. doi:10.1001/jama.2013.8522.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Subscribe to the journal
From The JAMA Network
JAMA Internal Medicine
Invited Commentary  | 
Finding Meaningful Patterns in Adverse Drug Event Reports
Joshua J. Gagne, PharmD, ScD
JAMA Internal Medicine
Invited Commentary  | 
Dopamine Receptor Agonist Drugs and Impulse Control Disorders
Howard D. Weiss, MD; Gregory M. Pontone, MD
JAMA Internal Medicine
Original Investigation  | 
Reports of Pathological Gambling, Hypersexuality, and Compulsive Shopping Associated With Dopamine Receptor Agonist Drugs
Thomas J. Moore, AB; Joseph Glenmullen, MD; Donald R. Mattison, MD, MS
JAMA Dermatology
Case Report/Case Series  | 
Drug-Associated Dermatomyositis Following Ipilimumab Therapy:  A Novel Immune-Mediated Adverse Event Associated With Cytotoxic T-Lymphocyte Antigen 4 Blockade
Shirwa Sheik Ali, BSc; Allison L. Goddard, MD; Jason J. Luke, MD; et al.